Inside the scientific demo working experience with Xyrem in narcolepsy/cataplexy clients at therapeutic doses, two individuals described stress and a person claimed insomnia next abrupt discontinuation within the termination with the scientific trial; in the two people with panic, the frequency of cataplexy experienced enhanced markedly simultaneou